Vera Therapeutics, Inc. Class A Common Stock (VERA) is a publicly traded Healthcare sector company. As of August 26, 2026, VERA trades at $35.40 with a market cap of $2.43B and a P/E ratio of -7.48. VERA moved +0.34% today. Year to date, VERA is -27.44%; over the trailing twelve months it is +65.32%. Its 52-week range spans $18.53 to $56.05. Analyst consensus is strong buy with an average price target of $78.00. Rallies surfaces VERA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for VERA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $35.40 |
| Market Cap | $2.43B |
| P/E Ratio | -7.48 |
| EPS | $-4.66 |
| Dividend Yield | 0.00% |
| 52-Week High | $56.05 |
| 52-Week Low | $18.53 |
| Volume | 7.77K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-299.62M |
| Gross Margin | 0.00% |
14 analysts cover VERA: 0 strong buy, 13 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $78.00.